Dantrolene low-volume (Eagle Pharmaceuticals)

N/A

Report date: 2024/05/11 20:00:08

Base Information

Drug NameDantrolene low-volume (Eagle Pharmaceuticals)
Drug Alias NameDantrolene (Eagle Pharmaceuticals)Dantrolene sodium (Eagle Pharmaceuticals)EA 111EP-4104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersRyanodine receptor calcium release channel modulators
TargetsVoltage-gated calcium channelRyanodine receptor calcium release channel
Therapy Area/IndicationsHeat StrokeMalignant Hyperthermia
Global Approved IndicationsMalignant Hyperthermia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2014/07/22
Country/TerritoryUnited StatesSaudi Arabia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLyotropic Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEagle Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMalignant Hyperthermia
Inactive IndicationsHeat Stroke

Other Information

ATC CodeN/A
Related LinksN/A